Shares in Glenmark Pharmaceuticals gain 2.5 percent after US health regulators approved Salix Pharmaceuticals Ltd's drug to treat diarrhoea in HIV/AIDS patients on qantiretroviral therapy, a combination of medicines used to treat HIV infection.
first published: Jan 1, 2013 02:14 pm
A collection of the most-viewed Moneycontrol videos.
Live: Sensex, Nifty retreat after mounting on new lifetime highs | Closing Bell
Live: Will bulls take Nifty to fresh lifetime highs today? | Opening Bell
Live: Nifty sees best single day rally since June 2025, nears record high | Closing Bell
Live: Can Nifty claim new lifetime highs in December series? | Opening Bell
